- Potential benefitReduces insurance-based disincentives that living donors face when seeking life, disability, or long-term care policies.
- Potential benefitMay increase willingness to donate by lowering perceived financial risk for potential living donors.
- Potential benefitClarifies FMLA coverage for donor recovery, strengthening leave protections for private-sector employees.
Living Donor Protection Act of 2025
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
The bill bars life, disability, and long-term care insurers from denying coverage or raising premiums solely because a person is a living organ donor, unless there are actual, unique, material actuarial risks. It amends the Family and Medical Leave Act and federal civil service leave law to explicitly include recovery from organ donation as a serious health condition and allows certain leave substitution for federal employees.
Liberal emphasizes donor protections and wants stronger enforcement
Relative to its intended legislative type, this bill provides clear substantive changes to protect living organ donors by prohibiting specified insurer actions, amending leave statutes, and mandating educational updates, but it leaves important implementation details—definitions of key actuarial standards, federal enforcement mechanisms, funding or appropriations, interaction with ERISA and state law, and accountability measures—under-specified.
The bill bars life, disability, and long-term care insurers from denying coverage or raising premiums solely because a person is a living organ donor, unless there are actual, unique, material actuarial risks.
It amends the Family and Medical Leave Act and federal civil service leave law to explicitly include recovery from organ donation as a serious health condition and allows certain leave substitution for federal employees.
The bill requires HHS to update public educational materials within six months about donation benefits, risks, and insurance impacts.
Short, targeted, low-cost public-health protections typically attract cross-aisle support, though insurer resistance and federalism questions create uncertainty.
Relative to its intended legislative type, this bill provides clear substantive changes to protect living organ donors by prohibiting specified insurer actions, amending leave statutes, and mandating educational updates, but it leaves important implementation details—definitions of key actuarial standards, federal enforcement mechanisms, funding or appropriations, interaction with ERISA and state law, and accountability measures—under-specified.
Liberal emphasizes donor protections and wants stronger enforcement
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenInsurers could face adverse selection pressure, potentially raising premiums for other policyholders.
- StatesState-by-state enforcement may produce uneven protections and variable regulatory outcomes across jurisdictions.
- Potential burdenInsurers might adopt alternative underwriting practices, increasing administrative complexity and compliance costs.
Why the argument around this bill splits.
Liberal emphasizes donor protections and wants stronger enforcement
This persona would view the bill favorably as it reduces barriers to living organ donation and protects donors from insurance discrimination.
They would applaud the explicit FMLA inclusion and HHS outreach.
They may push for stronger enforcement and broader coverage of other insurance types.
This persona would generally support the bill as a targeted, pragmatic measure to protect donors and clarify leave rules.
They would value the limited, specific scope but seek clarity on enforcement, costs, and insurer actuarial standards.
They would favor monitoring outcomes and making adjustments if problems arise.
This persona would be sympathetic to protecting donors but wary of federal preemption of insurance regulation and new mandates on insurers.
They would emphasize insurer actuarial freedom and state regulatory primacy.
Some conservatives might accept the bill as narrow and popular; others would seek more state control or carveouts.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Short, targeted, low-cost public-health protections typically attract cross-aisle support, though insurer resistance and federalism questions create uncertainty.
- Potential opposition from insurance industry or trade groups
- Legal challenges over federal intrusion into state insurance regulation
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberal emphasizes donor protections and wants stronger enforcement
Short, targeted, low-cost public-health protections typically attract cross-aisle support, though insurer resistance and federalism questio…
Relative to its intended legislative type, this bill provides clear substantive changes to protect living organ donors by prohibiting specified insurer actions, amending leave statutes, and mandating educational updates…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.